Publications

Show Filters

Searches all publications.

Search Fulltext

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-09-24
    E.g., 2018-09-24

Articles

51716 items
12:00 AM, Oct 02, 2000  |  BC Extra | Financial News

APBiotech files for IPO

APBiotech (Piscataway, N.J.) filed to raise up to $100 million in an IPO that will be underwritten by Morgan Stanley Dean Witter; Goldman, Sachs; Chase H&Q; and Salomon Smith Barney. APBiotech ( Amersham Pharmacia Biotech)...
12:00 AM, Oct 02, 2000  |  BC Extra | Financial News

MedImmune off on downgrade

MEDI was down $20.50 (27 percent) to $56.75 on Monday after Banc of America analyst Eric Ende lowered his rating to "market performer" from "buy." Ende lowered his non-U.S. sales estimate for MEDI's Synagis palivizumab...
12:00 AM, Oct 02, 2000  |  BC Extra | Company News

Discovery Partners and P&G enter screening deal

DPII division ChemRx Advanced Technologies will provide Procter & Gamble (PG) with compounds for drug screening over three years with the option to also provide hit follow-up and lead optimization....
12:00 AM, Oct 02, 2000  |  BC Extra | Company News

AxCell and Molecular Staging map protein pathways

AxCell Biosciences (Princeton, N.J.), a subsidiary of Cytogen (CYTO), and Molecular Staging ( Guilford, Conn.) will combine their technologies to map protein pathways. Molecular Staging will combine its Rolling Circle Amplification Technology to amplify and...
12:00 AM, Oct 02, 2000  |  BC Extra | Company News

Serono gets U.S. approval for Ovidrel

Serono (SWX:SEO; SRA) received FDA marketing approval for Ovidrel choriogonadotropin injection for the treatment of infertility. SEO plans to launch the product in the U.S. by the first quarter 2001, and is hoping for European...
12:00 AM, Oct 02, 2000  |  BC Extra | Company News

Exelixis, Artemis and Sangamo to develop knockout mice

EXEL, Artemis (Cologne, Germany) and SGMO will collaborate to develop a new method of generating knockout mice for functional gene validation. SGMO will use its knowledge of gene regulation and zinc finger DNA binding proteins...
12:00 AM, Oct 02, 2000  |  BC Extra | Company News

Orphan Medical submits NDA

ORPH submitted an NDA to the FDA for Xyrem sodium oxybate, an oral solution based on gamma hydroxybutyrate (GHB), to treat cataplexy and excessive daytime sleepiness (EDS) associated with narcolepsy....
12:00 AM, Oct 02, 2000  |  BC Extra | Company News

Dura and Glaxo in dermatology deal

DURA will exclusively distribute the dermatology product line from Glaxo Wellcome (GLX; LSE:GLXO). The line includes Cutivate fluticasone, Temovate clobetasol, Aclovate alclometasone, Oxistat oxiconazole and Emgel erythromycin. GLX will manufacture and supply the products in...
12:00 AM, Oct 02, 2000  |  BC Extra | Top Story

Affymetrix acquires Neomorphic

AFFX will acquire Neomorphic (Berkeley, Calif.) for 1.4 million AFFX shares, or $65.6 million based on AFFX's Monday close at $47.063. AFFX said it will apply Neomorphic's computational genomics and bioinformatics technology to developing products...
12:00 AM, Oct 02, 2000  |  BC Extra | Company News

Sequenom and Incyte to develop SNP assays

The companies will collaborate to develop validated SNP assays for use in genetics research. INCY will use its polymorphism detection algorithm to identify SNPs from its LifeSeq Gold database containing 120,000 transcribed genes. SQNM will...

Pages